Minor tranquilizers and brain defense systems.

Area of Science:

• Neuroscience
• Neuropharmacology
• Behavioral Science

Background:

• Minor tranquilizers (MT) are widely used for anxiety relief.
• Recent neurochemical research has elucidated the molecular mechanisms underlying MT action.
• Understanding these mechanisms is crucial for developing targeted anxiety treatments.

Purpose of the Study:

• To discuss the role of specific brain neuron systems in fear responses.
• To explain the anti-anxiety effects of minor tranquilizers (MT).
• To review the neurochemical basis of MT action and its impact on defensive behaviors.

Main Methods:

• Review of neurochemical research on MT mechanisms.
• Analysis of evidence on brain neuron systems involved in fear and anxiety.
• Integration of findings on the septo-hippocampal and brain aversive systems.

Main Results:

• MT decrease anxiety by impairing brain neuron systems that integrate defensive behavior.
• These systems include the septo-hippocampal system and the brain aversive system (periaqueductal gray, amygdala).
• MT's depressant action is likely due to facilitated gamma-aminobutyric acid (GABA) neurotransmission.

Conclusions:

• MT reduce anxiety by modulating neural circuits controlling defensive behaviors.
• Facilitation of GABA neurotransmission is the primary mechanism for MT's anti-anxiety effects.
• This research highlights the neurobiological underpinnings of anxiety and tranquilizer action.